Lantheus Holdings, Inc. (NASDAQ:LNTH) Director Derace L. Schaffer sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 10th. The shares were sold at an average price of $15.75, for a total value of $157,500.00. Following the transaction, the director now directly owns 63,730 shares in the company, valued at $1,003,747.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) traded up 2.03% during midday trading on Friday, reaching $15.10. The company had a trading volume of 1,004,070 shares. Lantheus Holdings, Inc. has a 1-year low of $2.51 and a 1-year high of $17.45. The firm’s 50 day moving average price is $15.76 and its 200-day moving average price is $11.80. The stock has a market capitalization of $562.67 million, a price-to-earnings ratio of 25.34 and a beta of 0.93.
Lantheus Holdings (NASDAQ:LNTH) last released its quarterly earnings data on Tuesday, May 2nd. The medical equipment provider reported $0.28 EPS for the quarter, topping the consensus estimate of $0.19 by $0.09. The company had revenue of $81.36 million for the quarter, compared to the consensus estimate of $77.75 million. Lantheus Holdings had a negative return on equity of 24.06% and a net margin of 6.71%. Equities research analysts expect that Lantheus Holdings, Inc. will post $0.93 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Markets Daily and is owned by of Markets Daily. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.themarketsdaily.com/2017/06/16/insider-selling-lantheus-holdings-inc-lnth-director-sells-157500-00-in-stock-updated-updated-updated.html.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Boothbay Fund Management LLC purchased a new position in Lantheus Holdings during the fourth quarter valued at approximately $128,000. DIAM Co. Ltd. purchased a new position in Lantheus Holdings during the third quarter valued at approximately $135,000. Koch Industries Inc. purchased a new position in Lantheus Holdings during the first quarter valued at approximately $153,000. BlueCrest Capital Management Ltd bought a new position in shares of Lantheus Holdings during the first quarter worth about $154,000. Finally, O Shaughnessy Asset Management LLC increased its position in shares of Lantheus Holdings by 218.9% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 19,463 shares of the medical equipment provider’s stock worth $167,000 after buying an additional 13,359 shares in the last quarter. Institutional investors own 64.27% of the company’s stock.
Several brokerages recently weighed in on LNTH. Jefferies Group LLC upped their price target on Lantheus Holdings from $15.00 to $18.00 and gave the stock a “buy” rating in a research note on Wednesday, May 3rd. Zacks Investment Research raised Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $17.00 price target on the stock in a research note on Thursday, May 4th.
About Lantheus Holdings
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.